Mersana Therapeutics (MRSN) Insider Trading & Ownership $2.22 0.00 (0.00%) (As of 11/20/2024 ET) Add Compare Share Share Insider Trades Stock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsShort InterestSustainabilityTrends Mersana Therapeutics (NASDAQ:MRSN) Insider Buying and Selling ActivityCurrentInsider OwnershipPercentage11.80%Number OfInsiders Buying(Last 12 Months)0Number OfInsiders Selling(Last 12 Months)7Amount OfInsider Selling(Last 12 Months)$256,846.84 Get MRSN Insider Trade Alerts Want to know when executives and insiders are buying or selling Mersana Therapeutics stock? Sign up for InsiderTrades.com's daily newsletter to get the latest insider transactions delivered to your inbox daily. Email Address MRSN Insider Buying and Selling by Quarter Ad Angel PublishingTesla Execs are Freaking OutIt’s so revolutionary that tech giants like Microsoft, Amazon, and NVIDIA are all lining up to get their hands on it. And Elon Musk has completely restructured Tesla to chase this opportunity. This is a once-in-a-lifetime opportunity that you don’t want to miss.Click here to get the details. Mersana Therapeutics Insider and Congressional Trades History Insiders and Members of Congress Insiders Only Members of Congress Only Transaction Type Custom Range 1 Month 3 Months 6 Months Year-to-Date 1 Year 2 Years 3 Years Time Frame * Start Date * End Date Export to Excel Transaction DateNameTitleBuy/SellNumber of SharesAverage Share PriceTotal TransactionDetails10/28/2024Mohan BalaSVPSell1,884$1.90$3,579.60 10/3/2024Alejandra CarvajalSVPSell5,598$1.96$10,972.08 10/2/2024Ashish MandeliaCAOSell4,855$2.00$9,710.00 10/2/2024Brian DeschuytnerCFOSell8,089$2.00$16,178.00 9/12/2024Martin H Jr. HuberCEOSell50,423$1.76$88,744.48 1/16/2024Anna ProtopapasDirectorSell29,399$2.71$79,671.29 1/16/2024Ashish MandeliaCAOSell5,025$2.71$13,617.75 1/16/2024Brian DeschuytnerCFOSell9,327$2.71$25,276.17 1/16/2024Tushar MisraSVPSell3,357$2.71$9,097.47 (Data available from 1/1/2013 forward) MRSN Insider Trading Activity - Frequently Asked Questions Who is on Mersana Therapeutics's Insider Roster? The list of insiders at Mersana Therapeutics includes Alejandra Carvajal, Andrew A F Hack, Anna Protopapas, Arvin Yang, Ashish Mandelia, Brian Deschuytner, Martin H Jr. Huber, Mohan Bala, Timothy B Lowinger, and Tushar Misra. Learn more on insiders at MRSN. What percentage of Mersana Therapeutics stock is owned by insiders? 11.80% of Mersana Therapeutics stock is owned by insiders. Learn more on MRSN's insider holdings. Which Mersana Therapeutics insiders have been selling company stock? The following insiders have sold MRSN shares in the last 24 months: Alejandra Carvajal ($26,314.24), Anna Protopapas ($179,237.33), Arvin Yang ($12,679.66), Ashish Mandelia ($43,848.25), Brian Deschuytner ($70,906.11), Martin H Jr. Huber ($88,744.48), Mohan Bala ($5,740.16), and Tushar Misra ($13,977.83). How much insider selling is happening at Mersana Therapeutics? Insiders have sold a total of 154,440 Mersana Therapeutics shares in the last 24 months for a total of $441,448.06 sold. Mersana Therapeutics Key ExecutivesDr. Martin H. Huber M.D. (Age 63)President, CEO & Director Compensation: $44kMr. Brian C. DeSchuytner (Age 45)Senior VP, CFO & COO Compensation: $626.32k1 recent tradesDr. Timothy B. Lowinger Ph.D. (Age 60)Senior VP and Chief Science & Technology Officer Compensation: $666.3kMs. Alejandra Veronica Carvajal J.D. (Age 50)Senior VP, Secretary & Chief Legal Officer Compensation: $606.51kMr. Mikhail Papisov Ph.D.Co-FounderMr. Ashish Mandelia (Age 49)VP, Controller & Chief Accounting Officer 1 recent tradesMr. Jason FredetteSenior Vice President of Investor Relations & Corporate CommunicationsMr. Chuck MillerSenior Vice President of Regulatory AffairsMr. Marc DamelinExe. Director and Head of Biology, Oncology, Antibody-Drug Conjugate ADC Discovery & Develop.Dr. Tushar Misra Ph.D. (Age 63)Senior VP & Chief Manufacturing Officer Compensation: $485.89k More Insider Trading Tools from MarketBeat Related Companies ARCT Insider Trading AVDL Insider Trading ZYME Insider Trading SEPN Insider Trading COGT Insider Trading BCAX Insider Trading BCYC Insider Trading PAHC Insider Trading COLL Insider Trading AVBP Insider Trading Insider Tracking Tools CEO Purchases/Sales CFO Purchases/Sales Top Insider Buying Stocks Top Insider Selling Stocks Insider Trades Screener Insider Trades Newsletter Congressional Stock Trades Insider Trading By Country U.S. Insider Trading Activity Canadian Insider Trading Activity U.K. Insider Trading Activity Australia Insider Trading Activity Latest Articles Insiders Selling Into 3 Rallies: Investors Should Do the OppositeInsiders Bet Big on These Small Cap StocksHere’s Why Etsy Management Is Investing $1 Billion in BuybacksInsider Buying Signals Upside for These 3 StocksBig Buybacks Announced: 3 Stocks Insiders Are Banking On This page (NASDAQ:MRSN) was last updated on 11/21/2024 by MarketBeat.com Staff From Our PartnersThe Crypto That’s Making Wall Street SweatThe Crypto Wall Street Is Desperate to Hide It's happening now, right under everyone's radar. Big tech gian...Crypto 101 Media | SponsoredMissed Nvidia? Watch this ASAPThis little-known project that Bill Gates has been quietly working on that’s about to unleash an AI breakthrou...Brownstone Research | SponsoredMusk’s new company could top a trillion?The investment legend who predicted the rise of Bitcoin, Facebook and streaming services like Netflix… Just...Paradigm Press | Sponsored24/7 Automated Profits in CryptoWhat if you could make consistent daily profits in crypto with minimal effort? Beyond trading lies a vast w...Crypto Swap Profits | SponsoredCrypto’s next big bull run?Juan Villaverde may be America’s top crypto expert. And he says something big is coming for crypto – on Nov...Weiss Ratings | Sponsored“This Changes Everything” - Trump Hands Millions Massive IRS GiftNow it's your time to return the favor by taking advantage of this tax "revenge loophole." Because even as ...Colonial Metals | SponsoredTim Sykes’ Urgent Trade Alert: “Make this move now”WARNING: 80 Wall Street banks are gearing up for MASSIVE D.C. shock This $2 trillion D.C. shock is NOT abou...Timothy Sykes | SponsoredUnveiled: NVIDIA’s "Secret Royalty" ProgramDid you know that there's an investment that will give you the opportunity to collect "royalties" every time N...Behind the Markets | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Mersana Therapeutics, Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Share Mersana Therapeutics With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.